633 related articles for article (PubMed ID: 20197746)
1. Topical treatment and combination approaches for vitiligo: new insights, new developments.
Hossani-Madani AR; Halder RM
G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
Hossani-Madani A; Halder R
G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
[TBL] [Abstract][Full Text] [Related]
3. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
4. A review of monochromatic excimer light in vitiligo.
Park KK; Liao W; Murase JE
Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical calcineurin inhibitors in vitiligo.
Wong R; Lin AN
Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
[TBL] [Abstract][Full Text] [Related]
6. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
7. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
[TBL] [Abstract][Full Text] [Related]
9. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
[TBL] [Abstract][Full Text] [Related]
11. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
Saraceno R; Nisticò SP; Capriotti E; Chimenti S
Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
[TBL] [Abstract][Full Text] [Related]
13. Photo(chemo)therapy for vitiligo.
Pacifico A; Leone G
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
[TBL] [Abstract][Full Text] [Related]
14. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
16. Current state of vitiligo therapy--evidence-based analysis of the literature.
Forschner T; Buchholtz S; Stockfleth E
J Dtsch Dermatol Ges; 2007 Jun; 5(6):467-75. PubMed ID: 17537039
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
18. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
20. Use of tacrolimus ointment in vitiligo alone or in combination therapy.
Berti S; Buggiani G; Lotti T
Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
